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In many regions of the world, brucellosis is an important zoonotic condition, In South Africa, 
it is a controlled animal disease, however in human it is only a reported condition. Brucella 
abortus is the principal pathogen, whereas Brucella melitensis has fewer predominant 
infections reported in animals and humans. Majority of South Africans still depend on livestock 
by-products such as milk for food. Multidrug resistance of Brucella which could be transmitted 
to humans through the food chain and close contact remains a big problem. The objectives of 
this study were to isolate and identify Brucella species recovered from raw milk, blood and 
lymph nodes of cattle, sheep and goats using culture and molecular profiling using PCR, to 
detect virulence genes of Brucella species and also determine the antibiogram of the isolates. 
Standard microbiological tests were used to identify Brucella spp. and all strains confirmed as 
belonging to the genus by genus-specific PCR primers. To determine the occurrence of 
Brucella virulence-associated genes, all identified isolates were further screened for the 
presence of the VirB5, VirB2, BtpA, BtpB, VceC, BetB, BPE275, BSPB and PrpA virulence-
associated genes. Detection of the Bru gene was observed in 120 isolates; 74 (62 %) from 
cattle; 16 (13.3%) in sheep and 33 (27.5%) from goats, lymph nodes had showed the highest 
isolates in cattle, while the blood samples were observed with highest isolates in sheep and 
goat. Brucella abortus isolates from cattle were susceptible to moxifloxacin (5 µg), gentamicin 
(10 µg), levofloxacin (5 µg), ofloxacin (5 µg) and cefixime (5 µg) (100%), while high-level of 
resistance (100%) to penicillin G (10 units), erythromycin (15 µg), ampicillin (10 µg), 
amoxicillin (10 µg), trimethoprim-sulfamethoxazole (2.5 µg) and rifampicin (5 µg) were 
observed. Intermediate resistance of deoxycycline (30 µg) (12%) was observed for Brucella 
melitensis in goats isolates and tetracycline (5 µg) (21%) and 44% for both goats and sheep 
respectively. A significant number of Brucella isolates had a MAR (Multiple Antibiotic 
Resistance) index > 0.2 indicating their source to be from high-risk sources, being previously 
exposed to antibiotics. Approximately 100% was observed for genes VecC and BetB from B. 
arbotus. While the lowest gene observed was PrpA at 4.6% from B. arbotus.   BetB was 
detected in 34.7% while virB2 and prpA (0%) were not detected in B. melitensis. Results of the 
present study showed that Brucella spp has a lot of different virulence genes isolated from the 
Eastern Cape region and that cattle are still the main reservoir for Brucella. Continuous 
monitoring and surveillance in the livestock industry must be ensured to mitigate the problem 
for public safety. 
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Worldwide, Brucella spp. are responsible for one of the most important zoonotic and 
contagious bacterial disease known as brucellosis, an ancient disease with worldwide 
prevalence, which has a large impact on human morbidity. Infection by this bacterium results 
in reproductive failure in livestock thus leading to a  huge loss economically, impacting the 
international trade (Gopinath, 2016). In human, infection is caused by the three species B. 
abortus, B. melitensis and B. suis (De Miguel et al., 2011). Additional economic impact as a 
results of Brucella infections include, loss in milk production, or no milk production, 
preventative programmes for humans as well as absenteeism from work can be costly and  
increase production costs (Shoukat et al., 2017). 
According to Department of Agriculture, Forestry and Fishery (DAFF), (2015) terrestrial 
wildlife species together with mammals have been a great source for documentation of Brucella 
spp worldwide. A number of wild animals in South Africa, namely; the hippopotamus, zebra, 
sable, eland, waterbuck and impala, have tested positive for brucellosis. Due to the infrequent 
contact with domestic animals like cattle, this species was not that important, but there has been 
an increase in contact between the two thus increasing the spread of bovine brucellosis in 
Southern Africa. 
Genus Brucella is a Gram negative, a member of the α-2 proteobacteria which causes 
brucellosis, which is a group of zoonosis infections that infect both animals and humans 
(Ducrotoy et al., 2017). Brucellosis affects humans by infecting the mucous membranes such 
as eyes and mouth, or by handling tissues that are infected. Brucella can lead to long term 
health problems for example, Malta fever in humans which can be chronic, and 
meningoencephalitis in livestock to mention a few, if not treated, may lead to acute or chronic 
forms, and the latter can lead to long-term health impacts (Mazyck et al., 2006, Franco et al, 
2007). 
Furthermore, ingesting contaminated food samples such as unpasteurized milk, milk products 
like cheese, and not ensuring that preventative measures are taken during slaughtering can also 
lead to the risk of contamination in humans (DAFF, 2015). Over the years Brucella species 
that were initially recognized, include B. abortus, B. melitensis, B. suis, B. ovis, B. canis and 
B, neotomae (Azam et al., 2016). All members of the genus brucella, genetically and 
immunologically are closely affiliated to each other thus, they vary at molecular level, as a 
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result they have a lot of virulence factors that cause undesirable pathogenicity (Razzaq, 
Alsaadi, & Al-yassari, 2014). 
Brucella melitensis is the main cause of human brucellosis and is usually associated with 
abortion of the foetus. This pathogen serves as the main contaminant in sheep and goats, 
whereas the reservoir for B. abortus is cattle (Wojno et al., 2016). It was reported that known 
bacterial pathogenic factors that directly harm eukaryotic cells, such as cytolisins, exotoxins, 
exoproteases and exoenzymes, and the expression of pathogenic determinants, like fimbriae, 
capsules, antigenic variation and plasmids was not found in brucella (Baldi & Giambartolomei, 
2013; He, 2012). However, we cannot rule out genes that were identified as virulence genes in 
other organisms if they are detected in Brucella. Because brucellosis is currently underreported 
in Africa and South Africa, and no complete treatment so far is available, only certain vaccines 
are administered, knowing more about the virulence genes for brucellosis, can help in finding 
a more complete treatment at a molecular level. 
1.2.PROBLEM STATEMENT 
Africa is  growing in population, hence milk and meat, which are animal based protein sources 
vital in the food industry, because they are abundant, safe and cheaper to produce (DAFF, 
2015). In South Africa, millions of people depend on this high-quality protein source for their 
wellbeing, making livestock production that is safe from contamination of brucellosis, is vital. 
There is a widespread contamination of milk and beef by Brucella species making brucellosis 
in South African livestock a problem to the economy mainly affecting the production system 
of cattle, impacting on the dairy as well as the beef industries. Even with only 10% of dairy 
herds infected, it can cause a chain reaction of millions of rands lost annually, that’s why it’s a 
controlled livestock disease in South Africa in terms of Animal Disease Act 35 of 1984 due to 
its impact in the economy (Du Preez and Malan, 2015). The organism also causes brucellosis 
in humans, making it a healthcare problem. 
From 1996 to 2004, between 291 and 457 bovine brucellosis outbreaks were reported yearly to 
OIE14 (OIE, 2008), showing that it has been long known in South Africa. High prevalence of 
brucellosis was reported in intensively farmed areas in Southern Africa because of the large 
number of livestock available. According to Godfroid (2004),  farmers in Southern Africa were 
reported to lose an estimated 300 million rand in 1990 due to the 14.7% of their herds being 
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infected. Bakunzi et al., (1993), reported lower sero-prevalance detected in remote rural village 
cattle as compared to higher sero-prevalence in peri-urban areas. 
Areas of poorly established domestic animals programme and improper public health 
programmes are the most prevalent areas (Wojno et al., 2016). The United States of America’s 
Center for Disease Control and Prevention (CDC) identified Africa as among the most 
commonly affected areas.  Human brucellosis in South Africa is considerably under diagnosed, 
hence under reported as in many parts of the world (Wojno et al., 2016). 
Because of the potential threat of the use of Brucella as a biological weapon, the interest has 
grown with regard to production of brucellosis. Growth of tourism and migration 
internationally, resulted in increase in infection of different wild and domesticated animals (Al-
Nassir, 2018). And also knowing the prevalence of virulence factors, and comparing them to 
other different virulence factors, we can determine which genes are found around which areas, 
or if different genes are responsible for virulence according to regions, this information can 
then be used to help with the control of brucellosis, specific methods can be developed to target 
specific genes. 
1.1. AIM AND OBJECTIVES 
AIM 
The aim of the study is to determine the prevalence of putative virulence genes associated with 




The objectives of the study are: 
 To test for antimicrobial susceptibility of different Brucella isolates obtained from cow 
raw milk. 
 To extract genomic DNA from isolates, determine the concentration and quality of 
DNA using a nano drop and gel electrophoresis. 
 To perform PCR amplification of the putative virulence genes of interest using primers 
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The genus Brucella belongs to phylum Proteobacteria, Class Alphaproteobacteria, Order 
Rhizobiales, and Family Brucellaceae. Becouse of the occurrence of pleomorphic forms, the  
structure of all Brucella spp. are justly constant, apart from old cultures (Scholz & Vergnaud, 
2013).This gram negative genus does not sporulate, require oxygen to grow, nonmotile and are 
coccobacilli (0.5- 1.5μm)   (Garin-bastuji et al., 1998). Different Brucella spp have different 
hosts, with Brucella melitensis, Brucella abortus, Brucella canis and Brucella suis being 
isolated or hosted mainly in sheep, goats, cattle, dogs and pigs. Sometimes a single host can be 
infected by two different species, for example, both B. abortus and B. melitensis can infect the 
cattle at the same time (Shoukat et al., 2017). 
Other species include B. Ovis which was also isolated from sheep (Buddle, 1965); B.neotomae 
from desert wood rat (Stoenner & Lackman, 1957). Recently other species of Brucella have 
been identified from cetaceans, pinnipeds (Foster et al, 2007) and voles (Scholz et al., 2008), 
which are B. ceti, B. pinnipediae and B. microti respectively. All members of the genus 
Brucella are closely related to each other but vay at molecular level, as a result, they have a lot 
of virulence factors that cause undesirable pathogenicity (Razzaq et al, 2014).    
2.2 Brucella species  
2.2.1 Brucella abortus 
Under normal conditions B. abortus, which is a facultative intracellular pathogen,  contaminate 
amongst others,  man, dog, horse, goats and sheep, but the main contaminate being cattle (Kudi 
et al, 1997). The difference is rather small between the nine B. abortus biovars (1-9), that so 
far have been reported [Centers of Disease Control and Prevention (CDC, 2005)]. Milk 
production decreases as a result of brucellosis infections in milk producing animals because 
somatic cell count in milk is multiplied, and  abortion increased, as well as postpartum metritis 
(Meador & Deyoe, 1989). Mainly bovine brucellosis is  an infection in  cattle, isolation in 
affected livestock usually happens in the uterus, udder, and lymphoid organs (Poester et al., 
2006; Xavier et al, 2010).   
According to Schelling et al. (2003) and Muma et al. (2007), because cattle are the dominant 
distributor of bovine brucellosis in farmyards, they undergo termination of pregnancy than non-
contaminated ones. Oral entry remains the pivotal route of infection by Brucella, such as taking 
in food or water that is infected as well as licking aborted foetuses or new-borns from 
contaminated cows (Díaz Aparicio, 2013).  
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Brucella is passed on to the calves by their mothers through the milk that they consume (Díaz 
Aparicio, 2013). Because sometimes the same teat cups can be used during milking, this 
increases the risk of cow to cow infection in milk producing farms (Díaz Aparicio, 2013). As 
a result milking of healthy cows before contaminated cows can reduce the spread of brucellosis  
(OIE, 2008; Samartino, 2003; Samartino & Enright, 1993). 
 
 
2.2.2 Brucella melitensis 
Amongst all the species under the genus Brucella, this is the most virulent one, and within the 
three biovars it contains, 1 and 3 are the ones identified regularly  in areas such as the Middle 
East, Latin America and also the Mediterranean which are sheep rearing locations (Banai, 
2002; Lucero, 2008; McDermot et al, 2013). Because of the negative economic impact 
brucellosis has on the trade industry of both animals and their by-products, it has been classified 
as a very strong zoonosis (Banai, 2002; Benkirane, 2006; Seleem et al, 2010). Sheep and goat 
are the most favoured hosts for B. melitensis, but goats remain B. melitensis’s  classic and 
natural hosts, cattle and other ruminants can also be affected (Verger et al, 1995).  
Even though B. melitensis and B. abortus contamination is the same for ruminants and cattle 
respectively, the main difference in ruminant’s infection from brucellosis is, stillbirths and 
abortion. This usually occurs in the latter stages of pregnancy and its only once in a lifetime 
(Blasco & Molina-Flores, 2011; Elzer et al., 2002). Contamination usually happens by means 
of close contact of infected animals’s secretions from genital tract of females (Alton, 1990) , 
whereas calves are contaminated by B. melitensis via consumption of tainted milk from their 
mothers (Álvarez et al., 2011; Kahler, 2000; Verger et al., 1995). Infections of the udder and 
contamination of milk by the bacteria results from two third contamination of goats by B. 
melintesis during pregnancy (Díaz Aparicio, 2013).   
2.2.3 Brucella ovis 
Countries in Europe known for sheep-raising are mostly contaminated by B. ovis because it 
infect sheep, other countries include but not least, Australia, North and South America, New 
Zealand, and South Africa (Burguess, 1982; DAFF, 2013). Infections such as epididymitis and 
sporadic loss of pregnancy in mature rams and ewes respectively is caused by B. ovis 
(Assadullah et al., 2010). Keeping rams in the same vicinity can also increase the risk of 
infection through direct contact, also ewes mating with contaminated ram in one season 
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(Machado et al., 2015; Carrera-Chávez, 2016). Starting at  30 days of gestation, B. ovis 
unusually results in loss of pregnancy related to placentitis in ewes (Xavier et al., 2010), 
resulting in weak lambs being born (Menzies, 2007). 
2.2.4 Brucella canis 
B. canis infects mostly tamed dogs, wild carnivores and sometimes other tamed animals, the 
growing pet industries will only result in an increase in Brucella infections. (Carmichael, 1990; 
Scholz & Vergnaud, 2013). The geographical location of the B. canis has been found to be 
around America, especially South and Central (Xavier et al., 2010). Usually transmission of  
B. canis can happen in a way of direct contact  with contaminated foetus, placenta or foetus 
fluids, resulting in infertility, abortions, testicular atrophy (Greene & Carmichael, 2006). 
Nevertheless contamination by this specie is  very unlikely and is not serious, even though it’s 
a zoonotic agent (Xavier et al., 2010). Accidental laboratory contamination and close contact 
with affected dogs or animals has been the only way humans got contaminated with B. canis 
(Wanke, 2004). 
2.2.5 Brucella suis 
In areas where brucellosis is a regular occurrence in cattle, tamed pigs are less likely to be 
infected by B. abortus and B. melitensis, but most likely to be contaminated by B. suis (Díaz 
Aparicio, 2013). Worldwide, only 3 (1, 2 and 3) biovars are the primary cause of porcine 
brucellosis out of the total of five, according to the European Food Safety Authority (2009). B. 
suis can also infect humans, espercially biovars 1 and 3, in regions such as America (North, 
South and central), Europe, Southern Asia and the Pacific (Frye, 1991; Scholz & Vergnaud, 
2013).  
Clinical diagnosis of B. suis infection in pigs can be rather difficult because of the lack of 
clinical signs, but in other cases it can be categorized by a genital infection with abortions (Díaz 
Aparicio, 2013). According to Olsen and Tatum (2016), other organs such as bones and joints 
can also be affected. Artificial insemination with infected boar’s semen, bringing into contact 
between infected and non-infected animals and wildlife reservoirs, remains the biggest way of 
infection of pigs by porcine brucellosis in farms (Díaz Aparicio, 2013).  
2.2.6 Brucella maris (B. ceti and B. pinnipedialis) 
Seal, whale, dolphins and other sea animals have always been the main hosts for sea Brucella 
strains, since the 1990’s. (Clavareau et al., 1998; Ewalt, Payeur et al., 1994; Foster et al., 1996; 
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Ross et al., 1994; Wyatt, 1999). All marine Brucella were originally grouped under one specie, 
but recently these specie have been sub-divided into two species, namely B.ceti (cetaceans) and 
B pinnipedialis (seals), from originally being called B. maris  (Foster et al., 2007).  
These Brucella sea isolates don’t only infect sea animals only, but also humans as well through 
direct contact or eating contaminated marine animals (Xavier et al., 2010), sometimes there 
has been cases of human brucellosis were there was no evidence of direct contact between 
patient and marine animals (Hernandez-Mora et al, 2008; McDonald et al., 2006; Sohn, 2003) 
, with having a connection with neurological disorder in humans for some cases (Hernandez-
Mora et al., 2008; Sohn, 2003). 
2.2.7 Brucella neotomae 
Not a lot has been reported of this specific Brucella spp, being discovered in 1957, B. neotomae, 
has been known to contaminate under normal situations the dessert wood rat in  the United 
States of America (Stoenner & Lackman, 1957). 
 
2.2.8 Brucella microti 
The fact that  B. microti has been isolated in South Moravia  and Czech Republic (Scholz et 
al., 2008), in the late 2000’s, from Voles (Microtus arvalis) and in Austria at a later stage from  
mandibular lymph nodes of wild red foxes (Vulpes vulpes) (Scholz et al, 2009) shows that there 
might still be a lot of information that is unknown about this specie and the genus  as a whole 
that is yet to be discovered world wide. Due to its location B. microti, is very important, because 
since its found in soil, all other information pertaining to environmental impact, distribution, 
ecology, genomic organization, zoonotic potential  and how it interacts with other species 
requires immediate attention (Anderson et al, 1986). 
2.3 Diseases caused by Brucella species 
2.3.1 Brucellosis in livestock 
Birth of weak offspring’s or late term abortion can result from B. abortus infection in cattle 
(Olsen & Tatum, 2016). Infection during initial birthing usually results in abortion, but after 
that birth becomes normal, with occasional bacterial shedding. Uterine secretions were found 
to contain brucellae during the second birthing subsequent to infection with 20 percent of cows, 
88 percent of cows had given off brucellae in their colostrum, among the negative uterine fluid 
cultures (Manthei & Carter, 1950). Temporal or development of concealed infection may result 
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in calves that are contaminated at birth, these calves can show no signs of infection and maybe 
serologically negative until they first give birth which can then result in abortion and a change 
from seronegative to seropositive is also observed this point (Wilesmith, 1978, Nicoletti, 1984).  
Absentia of seen particles and low leukocyte count result in high milk quality (Emminger & 
Schlam, 1943), and shedding of infection into milk is usually an expected outcome resulting 
from Brucella infection, even when signs of mastitis are not typically present (Morgan, 1960).  
It has been reported that different geographical locations highly influence difference in 
frequency of disease presentation, due to B.abortus biotypes or even the difference in cattle, 
for example, in Sudan’s western region, ostreoarticular lesions have been linked to infection 
by Brucella, with 92 percent of Zebu cattle with hygromas and 62 percent with arthritis were 
seropositive for brucella (Musa et al., 1990).     
Seminal vesiculitis and epididymitis are usually connected to orchitis, and it will remain 
concealed in bulls and sometimes infertility is also not observed (Eaglesome & Garcia, 1992, 
Neta et al., 2010). There is also Brucella abortus infection in other wildlife’s, such as buffalo, 
elk and Yak amongst others, which the infection closely relates to infection in cattle (Olsen & 
Johnson, 2011, Kreeger et al., 2000, Jackson et al., 2014, Nicoletti, 1980).   
Goats can also be infected by Brucella melitensis which strongly resembles B. abortus infection 
in cattle goats. Amongst all the animals infected by brucella Sheep are the most invulnerable 
to infection and also this is likely to be influenced by difference amongst breeds (Alton, 1990), 
and also unlikely to experience abortion. Even though shedding in milk over succeeding 
pregnancies has been seen to occur, shedding is less likely to reoccur in uterine and is very 
short in the following pregnancies (Tittarelli et al., 2005).   
Epididymitis and weakened fertility is caused by Brucella ovis in male sheep (Menzeis, 2007), 
in goats infection has not yet been reported to occur naturally, but experimental infections are 
most likely to occur (Burgess et al., 1985, Ridler et al., 2000). About 30-50 % serologically 
positive rams have lesions that are perceptible (Poester et al., 2006, Van Metre et al., 2012). In 
rams that don’t show any signs of infection, shedding of brucellae in semen still occurs, and 
can be spread across the herd, as a result reduction in fertility can be observed.  Birth of weak 
lambs or even abortion has been seen to occur in ewes even though infection is less likely 
(Poester et al., 2006, Menzies, 2007).   
Swine infection by Brucella suis is very organized and regularly observed, and lasting for a 
long time. Osteoarticular lesions are very common in swine, making it very distinct from other 
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animals, even if sometimes they don’t show any signs of infection. Abortion, weak piglets, 
orchitis, and epididymitis are the usual reproductive signs for Brucella suis infection.  (Poester 
et al., 2006). 
Dogs also go through reproductive lesions as a result of Brucella infection, where late term 
abortion is the most likely expression of this infection in bitches. There can also be large 
number of brucellae in the vaginal discharge, weeks after abortion. Infertility can be caused by 
orchitis and epididymitis in males. Bacteremia seen in swine can also be observed in dogs. 
Infection by B. canis in dogs can also result in discospondylitis, meningoencephalitis, and 
uveitis sometimes (Hollett, 2006, Wanke, 2004). 
 
2.3.2 Human brucellosis 
In human brucellosis, detection is complicated due to being characterized as a ‘protean 
manifestations’ (Pappas et al., 2005). Because human brucellosis has flu like symptoms, it has 
been called Malta fever or undulant fever with an approximate of 53-100% patients infected 
with it (Franco et al., 2007).  This disease can infect any organ in the human body, and can be 
chronic as well, but it’s less likely to be fatal. The stage of disease, the species involved in 
infection and the organ system affected can influence clinical features of brucellosis in humans 
(Pappas et al., 2005), with 3 months incubation time and symptoms manifesting with just only 
2-6 weeks after exposure (Sauret & Vilissova, 2002, Reguera et al., 2003).   
The most usual symptoms include fever, joint pain, night sweats, and more ratified symptoms 
such as anorexia, weakness and weight loss, with only 10-30% patients experiencing 
complications and skeleton infection being the most common (Araj, 1999, Reguera et al., 
2003). According to Pappas et al., (2005), peripheral arthritis, sacroiliitis, and spondylitis are 
the three unmistakable forms of osteoarticular disease resulting from brucellosis infection in 
patients (Pappas et al., 2005), and of the three forms, spondylitis is the most complicated to 
treat and can be linked to other complications such as neurological problems. 
Spontaneous abortion and epididymo-orchitis have been seen as a result of Brucella infection 
in the reproductive system, which is the most likely area to be infected. Only 2% of patients 
undergo cardiac complications, even though endocarditis has been identified as the leading 
cause of death from Brucella infection. Surgical valve replacement sometimes is required for 
the aortic valve, as it’s the most commonly infected part, together with an extended antibiotic 
therapy to remedy the infection (Reguera et al., 2003).  
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Severe diseases in humans are most often caused by B. melitensis and B. suis infection than B. 
abortus, as a result of such clear causative factors for severe disease in humans, very few 
studies have done interspecies comparison for disease manifestation (Troy et al., 2005).  
Infection by B. melitensis which is a more toxic disease than the other Brucella strains to 
humans, is distinguished by ‘fever, abdominal tenderness, hepatosplenomegaly, 
thrombocytopenia, and liver enzyme abnormalities. And also, infection by B. abortus is 
distinguished by focal complications such as, ‘osteomyelitis, arthritis, or complications with 
pregnancy’.   
Inadequate length of antibiotic treatment can result in about 10% relapse in patients infected 
with brucellosis, but this usually occurs in a period of 12 months after initial infection (Pappas 
et al., 2005). Relapse after longer periods after initial infection has been reported, such as 28 
years after initial presentation as reported by Ogredici et al. (2010).  Even years after diagnosis, 
having completed the antibiotic treatment and a successful clinical cure for brucellosis, recent 
reports suggest that brucellae can still exist intracellular, sometimes even in asymptomatic 
patients and also patients with either chronic focal disease or complaints of chronic vague non-
focal illness (Vrioni et al., 2008; Castano & Solera, 2009).  Further studies are needed for 
complete eradication of brucellae, but also other studies suggest that clinical cure is very much 
possible to do so in many cases. 
 
2.4 Brucella virulence factors 
The harmfulness of Brucella species relies mainly on being able to persist inside cells of the 
host, long enough for sexual contact to occur, since the hosts always removes bacteria in 
reproductive secretions, as a result this allows passing of bacteria to the subsequent host. As a 
result of this persistence, they remain in the immune system of domesticated animals, such as   
cattle, goats, sheep, and swine, for a long time, because they only breed once or twice a year 
(Seleem et al., 2008).  
Brucella infect the host in a hidden way, that’s why they always don’t openly cause toxicity as 
compared to other bacteria, and also they lack classical bacterial virulence factors such as 
‘exotoxins, endotoxic LPS, cytolysins, a capsule, functional flagella, fimbriae, plasmids, and 
inducers of apoptosis (Seleem et al., 2008), as such their virulence factors; lipopolysaccharide, 
a two component system, type 43 secretion system, and a cyclic β 1, 2 glucans (CβG) has a 
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three way function: hiding of Brucella  from detection in immune system, protection from host 
and also evasion of  the immune system of the host (Seleem et al., 2008).  
 
2.4.1 Lipopolysaccharide (LPS) 
Brucella contain lipopolysaccharide (LPS), which is important for the integrity of the outer 
membrane (Cardoso et al, 2006). Brucella LPS demonstrates characteristics different from 
other LPSs (Lapaque, Moriyon, Moreno, & Gorvel, 2005). The LPS phenotype of Brucella 
species is either smooth or rough if they possess or lack the surface exposed O-polysaccharides 
(O-PS) chain respectively (Xavier et al., 2010). The O-PS is linked to virulence related with 
smooth LPS (S-LPS), in that, mutant smooth strains fail to survive in macrophages (Franco et 
al, 2007; Xavier et al., 2010).  
The LPS is smooth in B. melitensis, B. abortus, and B. suis and rough in B. canis (Lapaque et 
al., 2005). Brucella LPS has been shown to weaken antimicrobial host reactions by preventing 
complement activity, antibacterial- peptide attacks, and impeding the immune mediators 
formation (Forestier et al , 1999; Lapaque et al., 2005; Moreno et al, 1981). Bactericidal 
cationic peptides such as defensin NP-2, lactoferrin, cecropines, lysozyme, bactenecin-derived 
peptides, the defensin-like antibiotic polymyxin B, and the crude lysosomal extracts from 
polymorphonuclear leukocytes are prevented from acting against Brucella by LPS (Freer et al., 
1996; Lapaque et al., 2005; Martinez de Tejada et al, 1995; Riley & Robertson, 1984). These 
assist Brucella in surviving and replicating inside the cells.  
 
2.4.2 Cyclic β 1, 2 glucans (CβG) 
The cyclic β 1, 2 glucans (CβG) in Brucella are produced by cyclic β 1-2 glucan synthase and 
encoded by cgs gene (Ko & Splitter, 2003). Glucans are components of the bacterial periplasm 
with osmoregulatory and cholesterol-sequestering activity needed for existence of the organism 
in phagocytic and non-phagocytic cells (Ko & Splitter, 2003). Brucella glycans prevent 
phagosome development and modifies protein expression in vacuolar membrane, excluding 
proteins from lysosomes in Brucella-containing vacuole  (Arellano-Reynoso et al., 2005). 
These  pathogens evade merging of Brucella-containing vacuole with macrophages lysozomes 
using cyclic β 1, 2 glucans (Arellano-Reynoso et al., 2005). A Study by Arellano-Reynoso et 
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al. (2005) indicated the inability to prevent phagosome-lysosome fusion among the CβG 
deficient mutants and replication was abrogated.  
 
2.4.3 Two- component system 
For successful establishment of infection, Brucella must gain entry into the host cell (Lopez-
Goni et al, 2003). Brucella has a two-component BvrR/BvrS gene regulation structure acting 
through a cascade of phosphorylation to control gene expression (Franco et al., 2007). 
The Brucella BvrR/BvrS two-component controlling structure is highly comparable to the 
controlling and sensory proteins of Sinorhizobium and Agrobacterium necessary for 
endosymbiosis and pathogenicity in plants, and very similar to a putative system present in the 
animal pathogen Bartonella (Lopez-Goni et al., 2003). Mutations in the BvrR/BvrS genes 
hinder the entrance of B. abortus in non-phagocytic cells and weaken intracellular trafficking 
and virulence (Lopez-Goni et al., 2003). BvrR is a gene that codes for a reaction regulator 
protein whereas BvrS codes for a sensor protein with histidine kinase activity (Xavier et al., 
2010). 
This regulatory structure is necessary for recruitment of GTPase and actin filaments, and for 
sustaining bacterial outer membrane (Lopez-Goni et al., 2003; Xavier et al., 2010). It is 
postulated that this system modulates the 12 outer membrane, which is necessary for binding, 
cell incursion, and resistance to lethal cationic peptides (Vassalos et al, 2009). This system has 
a significant influence on the appearance of the surface proteins, coded for by Omp25 and 
Omp31 genes. It is believed that expression of such external proteins allows Brucella to attach, 
and enter the host cells while evading lysosomal pathway. Mutants that are flawed in this 
structure have weakened cellular permeation and improved obliteration by phagolysosomes 
(Vassalos et al., 2009). 
 
2.4.4 Type 4- secretion system  
Type 4 secretion systems (T4SSs) belong to  family of multiprotein complexes responsible for 
excretion of bacterial macromolecules and proteins throughout the bacterial cell envelope 
(Cascales & Christie, 2003). The Brucella type 4 secretion system (T4SS) is encoded by the 
VirB1-VirB12 genes, which are located on chromosome II (Delrue et al, 2004; Hong et al, 
2000; O’Cellaghan et al., 1999). It transports bacterial effector proteins into the host cells; the 
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effector molecules play a role in trafficking of the Brucella-containing vacuoles headed for the 
replication site (Franco et al., 2007).  
Characterization of mechanisms and virulence factors in Brucella, that can be involved in the 
mediation and intracellular persistence have been poor (Azam et al., 2016).The promoter that 
is upstream the virB1 gene manages the transcription of the virB operon (O’Callaghan et al., 
2002; Sieira et al., 2000). Brucella suis was the first Brucella spp  in which the virB operon 
was initially discovered, there after it was discovered in all other Brucella spp and  the presence 
of genomic sequences further proved the potential importance of this operon (O’Callaghan et 
al., 2002). 
 T4SS can  be subdivided into 12 subunits, which are further subdivided into five parts: the 
stretching needle complex (composed of VirB2), the core/outer membrane complex (composed 
of VirB7, VirB9, and VirB10), the linking stalk (probably composed of fragments from VirB5 
or VirB10), the inner membrane complex (composed of VirB3, VirB4, VirB6, VirB8, and the 
N-terminus of VirB10), and the ATPases/energy center (consisting of VirB4 and VirB11) 
(Fronzes et al., 2009; Low et al., 2014; Trokter et al., 2014).  
Amongst all the subunits of Brucella, VirB1, VirB7, and VirB12 don’t play any role in 
virulence, but the others do (Comerci et al., 2001; den Hartigh et al., 2004, 2008; Sun et al., 
2005). During screening of genes co-regulated by virB operon regulator, the two effectors, 
virB-co-regulated effectors such as Vec A and Vec C were only recently identified, even when 
the T4SS had already been discovered some fifteen years ago in Brucella spp (de Jong et al., 
2008). 
According to Myeni et al. (2013), during bioinformatics other genes such as BspA, BspB, and 
BspF, and BspF, together with BspC and BspE, were also discovered. Myeni et al. (2013) 
further states that BspA, BspB, and BspF are composed of 191, 187, and 428 amino acids, and 
contain the DUF2062 domain (Domain of Unknown Function 2062, Pfam database). The 
structural classification of proteins (SCOP) structural domain (flanked by two transmembrane 
domains), and the Gcn5-related N-acetyltransferases (GNAT)- family acetyltransferase 
domain, respectively (Myeni et al., 2013). The BspA and BspB which are ectopically expressed 
appear to localize at the endoplasmic reticulum (ER), whereas the BspF is found in and around 
the cytosol and plasman membrane (Myeni et al., 2013). When overexpressed, these three 
effecors inhibit the host cells’ protein secretory pathway in transfected cells, and also block 




2.5 Prevalent Brucella virulence genes isolated from domestic livestock in South Africa 
In a study conducted by Green et al., (2018) in Eastern Cape, South Africa, Brucella virulence-
associated genes were isolated from cattle, sheep, and goats in 4 municipalities. According to 
this study, two Brucella spp. were confirmed from a total of 130 isolates, which were B. abortus 
(62.3%) and B. melitensis (37.7%) and then they were screened for the presence of the ManA, 
ManB, Omp25, Omp31 and ZnuA virulence-associated genes. The results were as follows 
ManA (100%), Omp25 (100%) and Omp31 (34.6-76.9%) to be the highest genes detected while 
ManB (11.5-38.5%) and ZnuA (10.3-19.2%) were the lowest from all isolates in the 4 
municipalities. 
 
2.6.  Distribution and outbreak of Brucellosis in South Africa and Africa in humans and 
livestock 
There are an estimated 500 000 new cases reported every year around the world for brucellosis, 
which is one the most likely zoonosis (Azam et al., 2016). In South Africa, even if the exact 
occurrence is not known, brucellosis is still considered a priority zoonotic disease, with the last 
recorded incidence rate of >0.2 per 100 000 population, which was based on a survey done in 
1956 to 1959 (Frean et al., 2018). But the department of health indicated an increase rate of 
between <0.1 and 0.3 per 100 000 population yearly (Frean, 2018). The uncontrolled 
movement of cattle and also the shortage of vaccination of susceptible animals has contributed 
to this increase in incidence rate across the country (van Helden, 2016). 
Bovine brucellosis can be seen across all the nine provinces in South Africa, and is very 
concentrated around the Highveld regions and central arrears as seen in figure 2.1 below, which 
shows B. abortus outbreaks, which is a primarily cattle disease, from January 2015 to May 
2018 as reported by DAFF, (2018). Because of poor compliance with regard to vaccination and 
testing of brucellosis many cattle farmers in South Africa currently are at risk of having 
Brucella positive cattle within their herds (Frean, 2018). 
For an example, there was an estimated prevalence of 0% - 1.5% in KwaZulu-Natal province 
in South Africa, (Hesterberg et al., 2008), Whereas due to larger herd and extensive animal 
movement together with sharing common grazing sites amongst animals around Africa, has 
led to an increase in prevalence rate (McDermott & Arimi, 2002). With the implementation of 
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the heifer vaccination in South Africa, this has led to the discovery of cattle being seen as the 
greatest source of outbreak (Hesterberg et al., 2008). 
 
Figure. 2.1. Reported Brucella abortus outbreaks in animals from January 2015 to May 2018 across all 
nine provinces of South Africa. Image courtesy of the Sub-Directorate: Epidemiology of the Directorate 
Animal Health, Department of Agriculture, Forestry and Fisheries (DAFF, 2019). 
 
Apart from the Nile delta and some Coastal strips, potential brucellosis hosts such as, cattle are 
found in the following countries in Africa, the Sahel and Ethiopian highlands and in Kenya, 
Tanzania, Uganda and other Eastern African countries of the Great Lakes area and in Southern 
African countries, namely Botswana, Madagascar, South Africa, South West of Angola, 
Zambia and Zimbabwe (Ducrotoy et al., 2017). In the South and North of Sahara and the tip 
of Africa, small ruminants are found in large quantities than cattle, even though sometimes 
there is overlapping, as shown in figure 2.2 a and b below. 
Production systems for livestock across Sub-Sahara Africa can be categorized according to five 
different groups, as shown in figure 2.2c and many cattle are evenly spread on mixed rain-fed 
systems, but some cattle can be found where grazing is the dominant production system 
(McDermott & Arimi, 2002).  In other words the lack of   intensive livestock production 
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systems and dominant patoralist where the cattle and small ruminants are kept together is the 
main driving factor (Ducrotoy et al., 2017). Human brucellosis in Africa due to its neglection 
is still a major problem, even with lack of epidemiological valid data (Ducrotoy et al., 2014). 
 
 
Figure 2.2. Brucella potential hosts and livestock production systems in Africa. Livestock density is 
expressed as the number of cattle (panel A) or small ruminants (B) per square kilometer according to 
categories of different sizes in order to clearly differentiate between zones of low and high livestock 
density (data derived from Gridded Livestock of the World; http://livestock.geo-wiki.org). Panel C 
shows the livestock production systems. Landless production systems are characterized by (i) less than 
10% of the income that comes from non-livestock agriculture, (ii) less than 10% of the feed dry matter 
that is farm produced, (iii) stocking rates of more than 10 livestock units per ha of agriculture land and 
(iv) a higher ruminant enterprise value than that of pig or poultry. In mixed farming systems the non-
livestock agriculture is responsible for a considerable part of the income. A distinction is made between 
rain-fed crops and land that is irrigated. In the remaining non-mixed farming systems, livestock depends 
on grazing activities whether extensively mobile as pastoralists or not. Land inaccessible or unsuitable 
for livestock is mainly categorized under “Other type” 
 
According to McDermott et al. (2013), observations were made from 500 000 animals, 30 000 
people and 600 food samples to determine the economic impact of brucellosis in about 259 
studies across Africa and Asia, which showed that sheep and cattle have a much higher 
prevalence range than other animals such as pigs and goats while veterinarians, livestock 
handlers and abattoir workers have a higher prevalence rate than patients who are in hospital   
(Zinsstag et al., 2013). 
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2.7 Laboratory identification of Brucella  
2.7.1. Staining 
Chlamydophila abortus and Coxiella burnetii can be used as reference point because they are 
abortive agents and they stain red can be used to check for aborted material, hence the use of 
stamp staining method is used even though it’s not specific but it gives a good indication (Alton 
et al., 1988).  
 Brucella spp. which are gram negative and resist weak acid treatment,  usually occur singly 
and are observed in clusters of two or more and also they are coccobacillus measuring 0.6-1.5 
μm long and 0.5-0.7 μm wide in size stain red after stamp staining (Godfroid et al., 2010). 
 
2.7.2. Culture 
In biotyping of strains, isolation of bacteria is always performed. This is also the case with 
brucellosis diagnosis, where the choice of sample is very critical as it depends on clinical signs 
observed. Hence valid samples are needed for diagnosis, samples such as aborted foetuses 
(stomach, spleen, and lung), foetal membranes, vaginal secretions, colostrum, milk, sperm, and 
fluid collected from the knee or hygroma (Alton et al., 1988).  
Farrell medium is the medium of choice when isolating Brucella spp., because it contains 
antibiotics that prevent other bacteria from growing and only allows Brucella spp., To grow 
(Alton et al., 1988). Different  Brucella spp. have different CO2  requirements based on their 
different biovars, biovars between 1-4 need CO2 (B. abortus wild type), while biovars 5,6,9 
don’t need CO2 for growth others, such as B. abortus wild type (biovars 5, 6, 9), B. abortus 
S19 vaccine strain, B. melitensis, and B. suis, (Chisi et al., 2017).  
 
2.7.3. Serological tests 
There are lots of serological tests that can be used in the characterization of Brucella spp., but 
Rose Bengal Test (RBT), Serum Agglutination Test (SAT), and Complement Fixation Test 
(CFT) are widely used. Buffered Brucella antigen test also known as RBT relies heavily on 
reduction of the ability of immunoglobin antibodies to bind to antigen under low pH conditions 
(Corbel, 2006b). According to Serra and Vinas (2004), the principle of RBT is that when 
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stained antigen and serum mix together, any agglutination that results shows a positive reaction 
(Serra and Vinas, 2004).  
The SAT has always been used as an alternative to the RBT, because of its lack of sensitivity 
and specificity even though its cheap (Agasthya et al., 2012; Clavijo et al., 2003; Vancelik et 
al., 2008). In contrast to the SAT, the CFT has good sensitivity and specificity, but difficult to 
perform and is very costly as well in terms of facilities and  staff  needed (Corbel, 2006a).  
 
2.7.4. Molecular characterization 
For the identification and characterization of Brucella spp. Many different polymerase chain 
reaction (PCR) techniques have been developed, because such methods often rely on detection 
of specific genes or sequences such as the Bru gene, 16s-23s ribosomal ribonucleic acid 
(rRNA) coding for Brucella spp. and also the bcsp31 gene encoding a 31-kDa protein (Baddour 
& Alkhalifa, 2008; Khamesipour, Rahimi et al., 2014; Ouahrani-Bettache et al., 1996).  
Because of its sensitivity, PCR can detect very small amounts, even only after 24 hours 
incubation, this helps with early identification and treatment. Other various target genes such 
as., Omp25, Omp31, ManA, etc. within the Brucella spp, have also been identified by PCR to 
detect Brucella virulence-associated (Gee et al., 2004).  
 
2.8 Antibiotic resistance 
Brucellosis is a very important zoonotic disease for both animals and human respectively. 
There has been a lot of attention directed towards development of antibiotic therapy for humans 
with various combination of drugs tried sometimes alone or in combination, drugs such as 
doxycycline, rifampicin, streptomycin, and corticosteroids have been used to treat simple 
infection or treat chronic infection of brucellosis with successful outcome; but setback have 
been reported in other cases. Currently  there is no definite treatment of brucellosis in livestock 
(Ghodasara et a.l, 2011), this is because of the evasive nature of Brucella infection. 
Both phagocytic and non-phagocytic cells can be infected by Brucella, (Miraglia et al., 2018). 
By inhibiting the phagosome-lysosome fusion, which result in survival, intracellular 
replication, and chronic infection of the host cells, small number of Brucella are able to escape 
the killing mechanisms of the host (Bellaire et al., 2005; Starr et al., 2008 and Celli et al., 
2003). As a result of this Brucella have many unique mechanisms that they use to evade 
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detection by the innate immune system and are able to evade antibiotics used as well, this is 
also called adaptive immunity (Baldwin et al., 2006). 
However, there are many different antibiotics that have been found to be effective in routine 
treatment of Brucella species, antibiotics such as rifampin, tetracycline, 
trimethoprim/sulfamethoxazole, deoxycycline, quinolones, streptomycin and ceftriaxone gave 
good results during treatment. But a combination of deoxycycline together with streptomycin 
or rifampin has been put forward by World Health Organization (WHO) in their guidelines for 
Brucella treatment [Food and Agricultural Organization (FAO)/(WHO) 2000; Young 2009]. 
 
2.9 Prevention and treatment measure for Brucellosis 
2.9.1 Livestock prevention and treatment 
2.9.1.1. Control Brucellosis and control of unrestricted animal movements 
Veterinary services for animals must be improved and new and improved diagnostic 
methodologies must be developed to control the spread of brucellosis, this can be achieved by 
normalizing all diagnostic kits and vaccines (Pappas et al., 2006). Monitoring of infected 
animals and reporting of new cases is very important in developing risk analysis, this should 
also include both domesticated and also wild animals (Rao, 2010).  
Checking the movements of animals is also very important, because if not checked, infected 
animals can be introduced to uninfected herds, if the status of those animals is not known, 
hence serosurveilance is very important. Maybe quarantine and serosurveilance of new animals 
before they are introduced into the herd  to ensure that these animals are free from brucellosis 
(Alton, 1990; Kabagambe et al., 2001; Refai, 2002).  
2.9.1.2. Vaccination 
Vaccination is one of the most economical methods to control any disease. Because of lack of 
or very limited vaccination for animals infected with brucellosis it can also lead to an increase 
in resistibility of the disease if it’s not administered continuously or consistently (Omer et al., 
2000). If done properly vaccination can help strengthen the host against brucella infections, 
hence reduce the risk of abortion and spread of brucellosis (Omer et al., 2000). B. melitensis 
strain Rev1 vaccine and B. abortus strain 19, strain RB51 are used in sheep or goat, and cattle 
respectively (DAFF, 2015). 
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Ruminants around the ages of three to four months can have immunity against brucellosis for 
three to five years when vaccinated with the Rev 1 vaccine (Blasco & Molina-Flores, 2011; 
Olsen & Stoffregen, 2005; Zinsstag et al., 2005). Only heifers between 4 to 8 months, which 
are sexually immature can be vaccinated by strain 19 of B. abortus against Brucellosis only 
once as required by law should  (Vemulapalli et al, 2002). Calves between 4 and 12 months 
are vaccinated by Strain RB51 (Vemulapalli et al., 2002).  
 
2.9.2 Human control, prevention and treatment 
2.9.2.1. Public health education, safety and hygiene 
Infection of brucellosis amongst humans can be increased by touching infected materials 
without proper protection and consumption of raw infected milk (Corbel, 1997), as such public 
education is very important towards brucellosis in order to minimize or reduce infections. 
Hence teaching individuals about risk factors, transmission, prevention, and dangers of 
brucellosis is of vital importance (Rahman et al., 2012). 
Pasteurization has been found to be very effective in killing Brucella spp. But this is not 
available across South Africa. Brucella strains can be killed by boiling milk for several minutes 
at 80–85 oC (Corbel, 2006a). During handling of animals, overalls, rubber gloves and rubber 
boots should be used for protection. But sometimes washing of hands with soap remains one 
of the most simple and effective ways to prevent infections, if gloves are not available is highly 
recommended (Samartino, 2003). 
 
2.9.2.2. Diagnostic  
Underreporting of Brucellosis in humans is of serious concern globally (Corbel, 2006a), as well 
as locally in South Africa. Consequently, treatment is not always available because of lack of 
diagnostic and medical tools. Hence the human health care system must contain appropriate 
test facilities for quicker and more precise diagnosis of brucellosis and also include a strong 
antimicrobial treatment regime prescription. 
A perfect test for diagnosis of brucellosis is yet to be advanced, which is related to vaccine 
development. Polymerase chain reaction (PCR) remains one of the most effective ways of 
diagnosing brucellosis in humans and livestock, together with detection of Brucella organisms 
or DNA through culture. Anti- Brucella antibodies in serum has been relied upon to properly 
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diagnose Brucellosis, because culture carries a lot of risk, such as contamination of staff and 
requires use of highly skilled staff in very high security laboratories and also it has poor 
sensitivity which can depend on host species and length of contamination (World Organization 
for Animal Health, 2009a,b and c).  
2.9.2.3. Treatment of human brucellosis     
The distinctive interchange with the human immune system makes Brucella difficult to cure, 
because brucellosis is most likely to become a chronic infection, hence this can only be solved 
by introducing timely diagnosis and treatment, which will prevent chronic infections (Ke et al., 
2015). With high treatment failure and relapse occurring at a very high rate (Ariza et al., 1995), 
brucellosis has become a very expensive disease to treat and this result in patients suffering 
when they can’t afford treatment (Franco et al., 2007), even with several treatments regimes 
currently available (Skalsky et al., 2008).    
For antibiotics to be effective, they need an appropriate length of time to be effective against 
all appearance of human brucellosis. Activity in vitro against Brucella spp has been observed 
for many different antimicrobial drugs (Corbel, 2006a; Seleem et al., 2010). According to 
Seleem et al., 2010, doxycycline amongst the tetracycline’s group are the drug of choice, 
because it can be administered twice per day for six weeks orally, whereas tetracycline is given 
every six hours or six weeks also, but because of the gastrointestinal side effects its rarely used 
(Seleem et al., 2010).  
An addition of aminoglycoside in treatment of human brucellosis is needed, because 
tetracyclines have between 10 and 20% relapse rate (Seleem et al., 2010). Streptomycin and 
gentamicin are two of the most favoured aminoglycosides, with streptomycin (1g/day 
intramuscularly) being the most preferred choice when used in combination with the 
tetracyclines, given for two to three weeks to patients (Corbel, 2006a). Single dose of 
Gentamicin on a daily basis is more active in vitro against Brucella spp. than streptomycin, but 
it is associated with unfavourable side effects (Corbel, 2006a).  
According to Abdel-Maksoud et al., 2012, there has been other combination of therapies, which 
are an alternative to the tetracyclines, which are doxycline-floroquinolone and trimethoprim-
sulphamethoxazole combinations (Abdel-Maksoud et al., 2012). Rifampicin, gentamicin and 
co-trimoxazole have been reported to offer alternatives for treatment of pregnant woman 
infected with brucellosis (Cekovska et al., 2010; FAO, 2006; WHO, 2005). All the treatment 
alternatives currently are not safe or reliable to be able to effectively and completely immunize 
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humans against brucellosis (Surendan et al., 2011), even with vaccines being developed 
worldwide. As a result of vaccination not being recommended, in the former Soviet Union and 
China have resorted to using live B. abortus strain 19-BA and 104M respectively (Seleem et 
al., 2010).  
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*This chapter deals with Identification of Brucella spp, DNA extraction and molecular characterization of 




Brucellosis is a widespread zoonotic disease which causes major public health and economic 
concerns. The objective of the study was to detect Brucella spp., determine antimicrobial 
susceptibility and identification of virulence-associated genes isolated from raw milk, blood, 
and lymph nodes samples of cattle, sheep, and goats. Samples were inoculated into Brucella 
selective media to recover Brucella isolates. Detection of the Bru gene was observed in 120 
isolates including 74 (62 %) from cattle; 16 (13.3%) in sheep and 33 (27.5%) from goats. 
Lymph nodes showed the highest isolates in cattle, and blood samples with highest isolates in 
sheep and goat. Brucella isolates were susceptible to moxifloxacin, gentamicin, levofloxacin, 
ofloxacin and cefixime (100%), while high-level of resistance (100%) to streptomycin, 
penicillin G, erythromycin, ampicillin, amoxicillin, trimethoprim-sulfamethoxazole and 
rifampicin were observed. Intermediate resistance was observed doxycycline (12%) in goats 
isolates and tetracycline (21%) and 44% for both goats and sheep respectively. A significant 
number of Brucella isolate had a MAR index > 0.2 indicating their source to be from high-risk 
sources, being previously exposed to antibiotics. The results of this study specifically indicate 
that cattle, goats and sheep in the East Cape are reservoirs of Brucella spp that are resistant to 
antibiotics and that they are the potential pool of antibiotic genes that may be spread to other 














Brucellosis in animals, both wild and tamed is caused by brucella spp. and their main reservoirs 
being sheep, cattle, swine, dogs, camels, and desert woodrats (Martirosyan et al., 2011; Bargen 
et al., 2012). Animals are not the only hosts for this bacterium, humans with direct contact with 
contaminated animals or products can contract brucellosis (Atluri et al., 2011; Bargen et al., 
2012). Body organs such as the liver, lymph nodes and reproductive tract can be more effected 
by brucellosis and also can lead to chronic lasting for several weeks (Atluri et al., 2011). The 
mucous membrane can be easily penetrated in natural hosts by brucella, leading to infection in 
the reproductive and respiratory tract (Ke et al.,2015). 
The two main brucella spp. B. melitensis and B. abortus, infect cattle and small ruminants  
resulting in infertility and abortions respectively, consequently causing enormous economic 
losses for the  community and the country (Corbel, 2006). Because of the poor reporting and 
misdiagnosis of brucellosis in other countries, the number of cases appear low. Even though 
few countries have never reported brucellosis infections, it is still a serious concern world-wide 
(Musallam et al., 2015). South Africa is one of the countries in Africa where information is 
still not distributed enough, considering that a lot of rural arears in the different provinces 
depend on livestock for sustenance and hence proper diagnosis of the causative agents of 
brucellosis is very important for the development of any control program, such as feeding the 
animals with antibiotics. 
Brucellosis can be managed through the use of antibiotics such as tetracycline, rifampin, 
trimethoprim-sulphamethoxazole (SXT), and streptomycin, administered orally or injected 
(Pappas et al., 2005 and Hall, 1991). Antibiotics are antimicrobial agents produced by 
microorganisms, they function by inhibiting or killing other microorganisms (Amabile-Cueva, 
2016). Because brucella is an intracellular bacterial pathogen that infects host macrophage 
cells, a specialized agent that is able to penetrate the macrophages and function within their 
cytoplasm is needed for the treatment of brucellosis. However, Brucella isolates are becoming 
resistant to the antibiotics recommended by World Organization Health (WHO) (Baykam et 
al., 2004).  
Treatment of brucellosis has always been a problem world-wide, with various combination of 
drugs be in experimented on or used, but this can lead to general misuse resulting in great 
concern for brucellosis treatment, because this can lead to resilience of the bacteria. However, 
during regular treatment other antibiotics such as, rifampin, tetracycline and few others have 
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been effective against brucella spp., but the World Health Organization according to their 
guidelines has put forward a mixture of doxycycline together with streptomycin as a possible 
treatment therapy for brucella infections (FAO/WHO, 2000; Young 2000). The aim of this 
study was to investigate the prevalence of putative virulence genes associated with Brucella 
abortus and Brucella melitensis isolates from livestock specimens in Eastern Cape, South 
Africa using molecular methods. 
 
 
3.2 Materials and methods 
3.2.1 Identification of Brucella 
3.2.1.1 Sample collection  
A total of 1955 samples comprising milk, blood, and lymph nodes were collected from 880 
cattle, 555 sheep, and 520 goats from the livestock production sector of the Amathole District 
Municipality (A), Buffalo City Metropolitan Municipality (B), OR Tambo District 
Municipality (C) as well as random samples collected from cattle slaughtered in Queenstown 
and East London abattoirs (D) in 2016. An amount of 10ml of blood samples were collected 
from cattle every Wednesday, from the caudal tail vein while those from sheep and goats were 
collected from the jugular vein. All samples were collected with individual needles and stored 
in 25 ml sterile EDTA vacutainer tubes (OIE, 2008). The tubes containing blood were 
immediately stored on ice until further analysis could be conducted. Raw milk samples, 10 ml, 
were collected in individual 100 ml sterile bottles from each quarter of dairy cows, sheep, and 
goats based on the method of Alton et al. (1989) and kept at 4°C for further analysis. Tissue 
samples of the mammary lymph nodes from cattle slaughtered in Queenstown and East London 
abattoirs were collected by the slaughtering staff personell and processed for bacterial isolation 
in accordance with the description of Alton et al. (1989). 
 
3.2.1.2 Bacterial isolation 
Centrifuge tubes containing 10 ml of milk samples were centrifuged at 6000 × g for 15 min at 
4 oC (Eppendorf 5430 R, Eppendorf). The cream and deposit obtained after the skimmed milk 
had been discarded were mixed and spread with a swab-stick on Brucella Agar (Merck, 
Johannesburg, South Africa) with Brucella supplement (Liofilchem, Roseto D.A., Italy). The 
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plates were incubated at 37oC with 5-10% CO2 to enhance anaerobic conditions. The presence 
of Brucella colonies was inspected after 2, 4, and 7 days. Blood from cattle, sheep and goats 
were inoculated into a Castaneda biphasic medium which consisted of both a solid and liquid 
Brucella medium (Merck, Johannesburg, South Africa) with Brucella supplement (Liofilchem, 
Roseto D.A., Italy). The Castaneda bottles were incubated for 21 days, supplemented with 5% 
CO2, with periodic tipping (OIE, 2008 and Carmichael, 1990). Lymph nodes were immersed 
in alcohol and flamed before being cut into small pieces and spread on the surface of Brucella 
Agar (Alton et al., 1989)   
3.2.1.3 DNA extraction and molecular characterization of Brucella species  
DNA was extracted from presumptive isolates using the Zymo Research bacterial or fungal 
mini-prep kit (Zymo Research Corp, Irvine, USA) following the manufacturer’s instructions. 
Genus-specific primers (Bru-F, Bru-R) for identification of Brucella sequences and species-
specific primers shown in Table 3.1, were used as described by Khamesipour et al., (2013) and 







Table 3. 1: Primer sets and amplicon sizes specific for the different Brucella species and vaccine stains. 









5 minutes initial denaturation at 95 oC followed by 35 cycles of 
denaturation at 94 oC for 45 seconds, 64.9 oC annealing for 1 
minute and 72 oC extension for 1 minute. A final elongation step 
at 72 oC for 7 minutes. 
245 (Khamesipour, 
2013) 




2 minutes initial denaturation at 94 oC followed by 35 cycles of 
denaturation at 95 oC for 20 seconds, 60 oC annealing for 20 
seconds and 72 oC extension for 30 seconds. A final elongation 
step at 72 oC for 7 minutes. 
498 (Ewalt and 
Bricker, 2000) 




2 minutes initial denaturation at 94 oC followed by 35 cycles of 
denaturation at 95 oC for 20 seconds, 60 oC annealing for 20 
seconds and 72 oC extension for 30 seconds. A final elongation 
step at 72 oC for 7 minutes.  









2 minutes initial denaturation at 94 oC followed by 35 cycles of 
denaturation at 95 oC for 20 seconds, 60 oC annealing for 20 
seconds and 72 oC extension for 30 seconds. A final elongation 
step at 72 oC for 7 minutes.  









2 minutes initial denaturation at 94 oC followed by 35 cycles of 
denaturation at 95 oC for 20 seconds, 60 oC annealing for 20 
seconds and 72 oC extension for 30 seconds. A final elongation 
step at 72 oC for 7 minutes. 
364 Ewalt and 
Bricker, 2000) 




2 minutes initial denaturation at 94 oC followed by 35 cycles of 
denaturation at 95 oC for 20 seconds, 60 oC annealing for 20 
seconds and 72 oC extension for 30 seconds. A final elongation 
step at 72 oC for 7 minutes. 




3.2.1.4 Gel electrophoresis 
Agarose gel (1.5%) was prepared using 1 × TBE buffer (10 × TBE buffer: 1M Tris, 1 M Boric 
acid, 50 mM EDTA, [pH 8.3]). The gel was stained with 5 µl ethidium bromide (165, 169). A 
KAPA universal DNA molecular weight marker and a 100 bp ladder (Fermentas) were used as 
size standards. Gel electrophoresis was performed at 100 V for 45 min and amplicons were 
visualized under UV light and photographed using an Alliance 4.7 XD-79 System (Uvitec, 
Cambridge, UK). 
3.2.2 Antibiotic Susceptibility 
3.2.2.1 Antibiotic susceptibility testing  
Susceptibility of Brucella isolates to 15 antibiotics – ciprofloxacin (5 µg), rifampicin (5 µg), 
amoxicillin (10 µg), doxycycline (30 µg), tetracycline (30 µg), trimethoprim + 
sulfamethoxazole (2.5 µg), ampicillin (10 µg), erythromycin (5 µg), ofloxacin (5 µg), cefixime 
(5 µg), moxifloxacin (5 µg), gentamicin (10 µg), penicillin G (10 units), levofloxacin (5 µg) 
and cefoxitin (30 µg) were determined using the Kirby Bauer disk diffusion method (Bauer et 
al., 1966), selection of this antibiotics were determined by the knowledge of the organism and 
its sensitivities. Briefly, Mueller-Hinton agar (Merck, Johannesburg, South Africa) plates 
supplemented with Brucella supplement (Liofilchem, Roseto D.A., Italy) were inoculated with 
bacterial suspensions calibrated to 0.5 McFarland standard turbidity using spread plate 
technique and antibiotic disks (Mast Diagnostics, Merseyside, United Kingdom) were applied.  
Plates were incubated at 37 oC in 5% CO2 for 48 hours and zones of inhibition were interpreted 
as resistant, sensitive, or intermediate using the interpretative chart method according to CLSI 
guidelines (CLSI, 2014).  
 
3.2.2.2 Multiple antibiotic resistance 
Multiple Antibiotic Resistance (MAR) phenotypes, patterns and indexing were generated for 
the resistant isolates (Ateba et al., 2008). The MAR index of individual isolates identified was 
calculated using the formula described by Krumperman (1983). MAR index of isolate = No. 
of antibiotics to which isolate was resistant / total no. of antibiotics to which isolate was 
exposed. A MAR index of ≥ 0.2 indicates a high-risk environment where antibiotics are often 





3.3.1 Confirmation of bacterial isolates  
The Bru gene was successfully amplified from 130 isolates of the 1955 total samples collected 
(Figure 3.1, Table 3.2). The highest number of isolates, 81(62.3%) was detected, in cattle, while 
the lowest number, 16 (12.3%), was observed in the samples from sheep.  The study detected 








Table 3.2: Molecular characterization of Brucella spp. from blood, raw milk and lymph nodes of cattle, sheep, and goats. 
Municipality Cattle Sheep Goats 




































A 405 16 16 2 0 135 13 0 13 0 215 10 0 10 0 
B 275 22 19 1 0 315 0 0 0 0 110 17 0 17 0 
C 100 21 19 3 0 55 2 0 2 0 100 3 0 3 0 
D 100 22 20 1 0 50 1 0 1 0 95 3 0 3 0 
Total 880 81 74 7 0 555 16 0 16 0 520 33 0 33 0 
Key*= Municipalities were named as A, B, C and to preserve confidentiality. 
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Figure 3.1: PCR products for the detection of B. abortus in raw milk, blood, and lymph node 
tissue samples. Universal DNA Ladder (Kappa); Lane 1: 13047K, Lane 2: Negative control, Lane 
3: 24, Lane 4: 212, Lane 5: 129, Lane 6: 10026K    Lane 7: ST13, Lane 8: EH35, Lane 9: EH 34, 
and Lane 10: ND12. The expected molecular size of the Bru gene is 245 bp. 
 
3.3.2 Brucella species characterization 
B. abortus (56.9%), B. melitensis (37.7%) and B. abortus vaccine strain S19 (5.4%) were 
confirmed from the isolates (Table 3.2; Figures 3.2, 3.3 and 3.4, appendix 1). B. melitensis Rev-1 
vaccine strain and B. abortus vaccine strain RB51 was not amplified from any of our samples. 
 




Figure 3.2: PCR products for the detection of B. abortus in raw milk, blood, and lymph node 
tissue samples.  Lane M: Universal DNA Ladder (Kappa); Lane 1: 13047K, Lane 2: Q24, Lane 3: 
24, Lane 4: 212, Lane 5: 129, lane 6: 10026K    Lane 7: ST13, Lane 8: EH35, Lane 9: EH 34, and 








3.3.3 Antibiogram profile 
Brucella isolates were susceptible to moxifloxacin, gentamicin, levofloxacin, ofloxacin and 
cefixime (100%).  These antibiotics may be used in the management of brucellosis in cattle, goats 
and sheep. Intermediate resistance was observed doxycycline (12%) in goats isolates and 













Table 3. 3: Antibiotic susceptibility testing of Brucella isolated from cattle, sheep and Goat. 
S=Susceptibility, I=Intermediate, R=Resistance
Antibiotics     Cattle    Total (%)      Goats     Total (%)     Sheep Total (%) 
S I R S I  R S I R S I R S I R S I R 
Ciprofloxacin (10 µg) 9 0 65 12 0 88 33 0 0 100 0 0 16 0 0 100 0 0 
Rifampicin (5 µg) 0 0 74 0 0 100 0 0 33 0 0 100 0 0 16 0 0 100 
Amoxicillin (10 µg) 0 0 74 0 0 100 0 0 33 0 0 100 0 0 16 0 0 100 
Doxycycline (30 µg) 0 0 74 0 0 100 0 4 29 0 12 88 0 0 16 0 0 100 
Tetracycline (5 µg) 0 0 74 0 0 100 0 7 26 0 21 79 0 7 9 0 44 56 
Trimethoprim- sulfamethoxazole (2.5 
µg) 
0 0 74 0 0 100 33 0 0 100 0 0 16 0 0 100 0 0 
Ampicillin (10 µg) 0 0 74 0 0 100 0 0 33 0 0 100 0 0 16 0 0 100 
Erythromycin (15 µg) 0 0 74 0 0 100 0 0 33 0 0 100 0 0 16 0 0 100 
Ofloxacin (5 µg) 74 0 0 100 0 0 33 0 0 100 0 0 16 0 0 100 0 0 
Cefixime (5 µg) 61 0 13 82 0 18 33 0 0 100 0 0 16 0 0 100 0 0 
Moxifloxacin (5 µg) 74 0 0 100 0 0 33 0 0 100 0 0 16 0 0 100 0 0 
Gentamicin (10 µg) 74 0 0 100 0 0 33 0 0 100 0 0 16 0 0 100 0 0 
Penicillin G (10 units) 0 0 74 0 0 100 0 0 33 0 0 100 0 0 16 0 0 100 
Levofloxacin (5 µg) 74 0 0 100 0 0 33 0 0 0 0 100 16 0 0 100 0 0 




3.3.3.1 MAR indices (MARI)  
Multiple antibiotic resistance (MAR) phenotypes and MAR indices (MARI)  
The characterization of Brucella spp. for their MAR phenotypes and MAR indices (MARI) is 
shown in Table 3.4. Forty-seven isolates were resistant to at least five (Rifampin, Amoxicillin, 
Doxycycline and Ampicilin) antibiotics. Multiple antibiotic resistances were observed against 5-
11 antibiotics. The predominant MAR phenotype was A5: CIPR ER PGR RPR AR DXTR TR SXTR 
APR which occurred in 35% of the Brucella isolates. On the other hand, the MARI for all the 
isolates ranged from 0.3- 0.7, with the mean being 0.5. 
Table 3.4. Antibiotypes and MARI of Brucella isolates. 
Antibioti
c code 
Antibiotype Number of 
antibiotics 
MARI 
A1  ER  PGR  RPR  AR  APR  5 0.3 
A2 ER  PGR  RPR  AR DXTR  APR  6 0.5 
A3 ER  PGR  RPR  AR DXTR TR APR  7 0.5 
A4 ER  PGR  RPR  AR DXTR TR SXTR APR  FOXR 9 0.6 
A5 CIPR  ER  PGR  RPR  AR DXTR TR  TSR APR   9 0.6 
A6 CIPR ER  PGR  RPR  AR DXTR TR SXTR APR  CFMR FOXR 11 0.7 
* A, amoxicillin; CIP, ciprofloxacin; DXT, doxycycline; PG, penicillin G; CFM, cefixime; SXT, 





Due to the rapid urbanization and accessibility in the past 10 to 20 years, the need for meat and 
milk increased tremendously (NDA, 2006). Therefore, any infectious disease that can affect 
this industry must be analyzed thoroughly, because if not checked it can even destroy the 
industry as a whole. An example of such an infectious disease is brucellosis, which is caused 
by the Brucella species (Cloeckaert and Vizcaino, 2004; Araj, 2010). This disease remains a 
worldwide problem, but it is particularly damaging in Africa, where similar livestock systems, 
environmental conditions and cultural principles are observed (Refai, 2002 and Gwida et al., 
2010). Currently cattle remain the main source for zoonosis in human infection. There is not a 
lot of control programs, but vaccination does exist (Islam et al., 2013).   
Source of infection of Brucella can vary amongst livestocks, both domesticated and non-
domesticated. Majority of total confirmed isolates for Brucella spp., were 62.3% from cattle, 
25.4% from goats, and 12.3% from sheep. According to the results, raw milk samples detected 
a lower number of the Bru gene as compared to lymph nodes in municipalities C and D (Table 
3.2). Because milk was collected from commercial dairy animals, the low incidence can be 
explained by the fact that farmers in those farms follow a strict vaccination and control strategy, 
minimizing infections on their milk and dairy products, where as in other small farms or non-
commercial farms where farmers don’t follow those strict vaccination protocols incidence of 
infection in milk might be higher (Hesterberg et al., 2008).  
Brucella had a high detection in lymph nodes than tissue samples, according to Corbel and 
Brinley-Morgan (1984). In this study, this resulted in higher detection in cattle (24%), followed 
by goats (3.1%) and finally sheep (0.8%), showing that even with lymph nodes detection, the 
amount of detection differed according to animals. Detection therefore of Brucella depends on 
the time it took for the organism to spread within the lymph nodes during infection, resulting 
in a  high number or a low number of incidence (Corbel and Brinley-Morgan, 1984; 
Khamesipour et al. 2013). This though was an outcome contrary to this study. The samples for 
this study were collected post-mortem, but this was indicated as being far from an ideal 
situation for a diagnostic test by O’Leary et al, (2006). 
According to Khamesipour et al. (2014), Bru gene was found in higher percentage in lymph 
nodes as compared to blood samples, this was in contrary to this study as this gene was found 
in higher percentage in blood samples than lymph nodes with Brucella identified in 23.9% of 




et al. (2006), whole blood in our study attested to be a good sample for Brucella detection. All 
the Brucella spp. were identified as B. abortus, B. melitensis, and B. abortus vaccine strain S19 
in this study. These results, agrees with the report of  Bricker and Halling, (1995) who observed 
the detection of these strains in similar samples.  
Within all the isolates, higher detection percentage was confirmed in  B. abortus (56.9%)  and 
the lower percentage in B. melitensis (37.7%), this was  contrary to a study done in Egypt by 
Mohamed et al., (2013), who detected a lower percentage (16.4%) of  B. melitensis from 
infected cattle and sheep, this then further strengthens observations made by  Corbel, (2006), 
that B. melintensis and B. abortus infected largely small ruminants and cattle, respectively. As 
previously reported, infection by Brucella can have a devastating loss in economy as a result 
of abortions and infertility (Mohamed et al., 2013).  This devastation can be compounded by 
the resistance of the organisms to commonly used antibiotics. 
Common residues found in milk, such as beta-lactams,  tetracyclines and aminoglycosides (e.g. 
streptomycin) are the type of classes of antimicrobials mainly used in treatment of diseases like 
mastitis in dairy cattle (Gustavsson et al., 2004). Antibiotic resistance in bacteria has a potential 
of becoming widespread, due to the misuse of antibiotics during treatment of mastitis, because 
of transmission of resistant zoonotic and non-zoonotic bacteria through food, resulting in 
increased severity if similar antibiotics are used to treat pathogens (Bywater et al., 2004; 
Mervius et al., 2005).  
Livestock may be an effective medium for the propagation of antimicrobial resistant Brucella 
spp. in the population (Watkins et al., 2016). Studies on drug-resistant Brucella isolates in 
South Africa are essential. In the present study antibiotic resistance showed a high-level 
resistance (100%) to streptomycin, penicillin G, erythromycin, ampicillin, amoxicillin, 
trimethoprim-sulfamethoxazole and rifampicin which was similar to what Maves et al. (2011) 
and Abdel-Maksud et al. (2012) observed in their studies. These results are however conflicting 
with the studies by Pauletti et al. (2015) who observed a 100% penicillin G and erythromycin 
sensitivity. Trimethoprim-sulfamethoxazole (TS) is is highly recommended for brucellosis 
treatment, mainly in children of younger than 8 years (Osudiya et al., 2013).  The resistance of 
Brucella to β-lactam antibiotics can be related to the popular use of penicillin in the treatment 
of animal diseases which results in an increase in resistance to antibiotics of β-lactam. 
Brucella isolates were susceptible to moxifloxacin, gentamicin, levofloxacin, ofloxacin and 
cefixime (100%).  These antibiotics may be used in the management of brucellosis in cattle, 
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goats and sheep. Intermediate resistance was observed doxycycline (12%) in goats isolates and 
tetracycline (21%) and 44% for both goats and sheep, respectively.  Adzitey et al. (2012) states 
that organisms that show intermediate resistance tend to easily become resistant.  
Multidrug resistance was observed in 39.1% of the isolates with different multiple antibiotic- 
resistant phenotypes (MARP). The predominant MARP was CIPR ER  PGR  RPR  AR DXTR TR 
SXTR APR  CFMR FOXR  found in 11 (9.1%%) isolates cutting across different patho-types. 
Other MARP showing resistance against 5–9 different antibiotics were also detected at 
different frequencies. One of the biggest effects of multiple antibiotic resistance is the restricted 
effective treatments available to combat brucellosis, which was previously considered to be 
curable. The reclassification of many illnesses as recurrent with relevant clinical effects such 
as prolongation of the illness, higher therapy costs and an elevated risk of mortality has been 
influenced by multi-drug resistance (Adzitey et al., 2012).  
In order to quantify health risks, associate to the proliferation of pharmaceutical resistance in 
the community, multiple antibiotic resistance index (MARI) was used. A multiple antibiotic 
resistant index (MARI) value of 0.2 is used to discriminate between low and high risk for 
infection, and the MARI value above 0.2 means that a strain of the bacteria is obtained from a 
high-pollution setting or from high antibiotic use (Osudiya et al. 2013). The MARI estimates 
obtained for isolates from our study ranged from 0.3 to 0.7 and are greater than 0.2, suggesting 
that the isolates originated from environments with high use or contamination of antibiotics. 
The high MARI values obtained in this study may suggest the exposure of the isolates to 
antibiotics pressure, which might have resulted from inappropriate use of antibiotics among 






3.6 Conclusion  
The results of this study specifically indicate that cattle, goats and sheep in the East Cape are 
reservoirs of Brucella spp that are resistant to antibiotics and that they are the potential pool of 
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antibiotic genes that may be spread to other pathogens in the population posing a risk to public 
health. There is major development of multidrug resistance overtime or acquired resistance that 
is shown by the Brucella spp, because appropriate measures are not put in place. This situation 
is worrisome as certain severe bacterial infections may lack therapeutic options in the near 
future. This problem, together with a large number of immunocompromised citizens in South 
Africa, demands that the spread of antibiotic resistance be monitored as a priority to ensure the 
health of the general population.  
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Brucella, has many different virulence factors that act as causative agents of brucellosis 
pending on the environment and other factors, some virulence factors may play a role more 
than others during infection and as a result play a role in becoming a causative agent for 
pathogenesis. Brucella melitensis and Brucella abortus are considered to be pathogenic to 
humans. The genetic regularity of nine potential causes of virulence of two Brucella species in 
Eastern Cape livestock was examined. A hundred and twenty isolates were used in the detection 
of virB2, virB5, vceC, btpA, btpB, prpA, betB, bpe275 and bspB virulence factors using PCR.  
Approximately 100% was observed for genes VecC and BetB from B. arbotus. While the lowest 
gene observed was PrpA at 4.6% from B. arbotus.   BetB was detected in 34.7% while virB2 
and prpA (0%) were not detected in B. melitensis. The results from this research suggest that 
most isolates of Brucella have virulence-related genes associated with disease pathogenesis. 
Our findings showed that Brucella strains in the Eastern Cape Province are extremely virulent 
as virulence characteristics exist in most strains investigated. 
 
4.1 Introduction 
Brucellosis is a condition most widely considered to have an impact on domestic animals and 
marine species. This disease can also infect humans as well through the intake of tainted food 
products or interaction with the infected animal (Hamdy & Zaki, 2018). The classification of 
this genus Brucella has always been according to the type of species they infect;  with B. 
melitensis infecting goats and sheep, while B. abortus infecting cattle, B. suis infecting pigs, B. 
neotomae infecting desert woodrats, B. ovis infecting rams, and B. canis infecting dogs, (Alton 
et al., 1988;  Godfroid et al., 2011). Other species have also been isolated from cetacean and 
pinniped species, such as B. ceti and B. pinnipedialis respectively (Foster et al., 2007), B. 
microti detected  from vole (Al Dahouk et al., 2003) and ultimately B. inopinata from human 
breast implants (Scholz & Vergnaud, 2013). 
The last group of Brucella spp. has a much lower  zoonotic potential than the first three 
traditionally big species, because of the high zoonotic potential, these first three  Brucella 
species may lead to a broad range of infections, including abortions in animals, leading to huge 
losses in economy locally and internationally, this has resulted in the increase in the 
implementation of programs to eradicate brucellosis in wide variety of animals, more especially 
cattle’s, and pigs (OIE, 2009).  
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All members of the genus Brucella strongly resemble each other according to their genetic and 
immunological evidence (Gandara et al., 2001). Hence the expression of their virulence factors 
such as antigenic heterogeneity, exopolysaccharides, exotoxins, exoenzymes, fimbriae, flagella 
and secretion processes are responsible for their pathogenicity (Bentley et al., 2005; Cossart et 
al., 2005; He, 2012). Even so, there is a level of dissimilarities in virulence and also the level 
of virulence differs according to animals, with humans and guinea-pigs very much the same 
level (Smith and Ficht, 1990). Brucella infect the host in a hidden way, without causing toxicity 
as compared to other bacteria because classical bacterial virulence factors including exotoxins, 
endotoxic LPSs, cytolysins, capsules, functional flagella, fimbrias, plasmids and apoptosis 
inductors are missing (Seleem et al., 2008), as such their virulence factors; lipopolysaccharide, 
a two component system, type 43 secretion system, and a cyclic β 1, 2 glucans (CβG) has a 
three way function: hiding of Brucella  from detection in immune system, protection from host 
and also evasion of  the immune system of the host (Seleem et al., 2008).  
The type IV (T4SS) secretion mechanism responsible for, the excretion of bacterial 
macromolecules and proteins in the microbial cells envelope belongs to the multi-protein class 
(Cascales & Christie, 2003). The T4SS structure can be broken down into 12 subunits which 
are further partitioned into five parts: the stretching needle complex (composed of VirB2), the 
core / outer membrane complex (consisting of VirB7, VirB9, and VirB10), the connecting stalk 
(likely composed of VirB5 or VirB10 fragments), the inner membrane complex (composed of 
VirB3, VirB4, VirB6, VirB8, and the VirB10 N-terminus), and the VirB10 energy centre 
(consisting of virB4 and virB11). Amongst all the subunits of Brucella, VirB1, VirB7, and 
VirB12 don’t play any role in virulence, but the others do (Den Hartigh et al., 2004).  
Other new proteins such as VirB-co-regulated effectors (Vce) like VceA and C, Brucella 
putative effectors (BPE), Brucella secreted proteins (Bsps) according to Myeni et al., (2013) 
have been discovered and also BtpA (Brucella TIR domain containing proteins), PrpA (proline 
racemase protein A) has also been discovered which triggers IL-10 secretion resulting in non-
responsiveness of the immune system during infection (Spera et al., 2006). BetB is another 
virulence factor which is involved in the oxidation of betaine aldehyde to glysine betaine using 
Nicotinamide Adenine Dinucleotide (NAD). 
Due to its effect on cattle, milk and other dairy related products as well as human infections, 
bovine brucellosis requires further investigation in order to minimize infection. The genetic 
predominance analysis of virulence-related genes is therefore very significant, especially in 
South Africa and even in Africa as a whole, for understanding and preventing the disease. The 
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objective of this study was to determine occurrences of nine putative virulence-associated 
genes from B. arbotus and B. melitensis isolated from cattle, sheep, and goats in selected 
municipalities of the Eastern Cape Province, South Africa. 
 
4.2 Materials and methods 
4.2.1 DNA extraction  
DNA was extracted from 120 isolates including, 81 (62.3%) cattle, 33 (25.4%) goats and 16 
(12.3%) sheep (Table. 4.1) in 4 municipalities using a Wizard Genomic DNA Purification kit 
(Promega® Corporation, Madison, USA) following the manufacturer’s instructions. 
 
4.2.2 Molecular detection of putative genes of Brucella 
Oligonucleotide primers targeting the VirB5 gene encoding linking stalk of the T4SS, VirB2 
gene for the stretching needle complex of the T4SS, BtpA and BtpB genes for TIR proteins, 
Vcec gene which is VirB-co regulator, Bet gene coding for betaine aldehyde dehydrogenase, 
BPE275 gene, BSPB gene and PrpA virulence gene were used in the polymerase chain reaction 
(Table 4.1). The PCR assays were carried out in a 25 µl reaction volume as described by 
(Hashemifar et al., 2017). 
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Table 4. 1: List of primers and PCR conditions for the amplification of Brucella virulence associated genes. 






TCACCGCTTCGTAGAGAT   
 
Initial denaturation at 94 °C for 4 min followed by 30 cycles of heat denaturation at 94 °C for 60 sec, primer annealing at 56 °C for 45 
sec and DNA extension at 72 °C for 1 min. Final extension at 72 °C for 10 min to complete synthesis of all strands. 








Initial denaturation at 94 °C for 4 min followed by 30 cycles of heat denaturation at 94 °C for 60 sec, primer annealing at 56 °C for 45 
sec and DNA extension at 72 °C for 1 min. Final extension at 72 °C for 10 min to complete synthesis of all strands. 







Initial denaturation at 94 °C for 4 min followed by 30 cycles of heat denaturation at 94 °C for 60 sec, primer annealing at 61 °C for 45 
sec and DNA extension at 72 °C for 1 min. Final extension at 72 °C for 10 min to complete synthesis of all strands. 







Initial denaturation at 94 °C for 4 min followed by 30 cycles of heat denaturation at 94 °C for 60 sec, primer annealing at 61 °C for 45 
sec and DNA extension at 72 °C for 1 min. Final extension at 72 °C for 10 min to complete synthesis of all strands. 







Initial denaturation at 94 °C for 4 min followed by 30 cycles of heat denaturation at 94 °C for 60 sec, primer annealing at 60 °C for 45 
sec and DNA extension at 72 °C for 1 min. Final extension at 72 °C for 10 min to complete synthesis of all strands. 









Initial denaturation at 94 °C for 4 min followed by 30 cycles of heat denaturation at 94 °C for 60 sec, primer annealing at 59 °C for 45 
sec and DNA extension at 72 °C for 1 min. Final extension at 72 °C for 10 min to complete synthesis of all strands. 







Initial denaturation at 94 °C for 4 min followed by 30 cycles of heat denaturation at 94 °C for 60 sec, primer annealing at 60 °C for 45 
sec and DNA extension at 72 °C for 1 min. Final extension at 72 °C for 10 min to complete synthesis of all strands. 







Initial denaturation at 94 °C for 4 min followed by 30 cycles of heat denaturation at 94 °C for 60 sec, primer annealing at 62 °C for 45 
sec and DNA extension at 72 °C for 1 min. Final extension at 72 °C for 10 min to complete synthesis of all strands. 







Initial denaturation at 94 °C for 4 min followed by 30 cycles of heat denaturation at 94 °C for 60 sec, primer annealing at 58 °C for 45 
sec and DNA extension at 72 °C for 1 min. Final extension at 72 °C for 10 min to complete synthesis of all strands. 
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(Hashemifar et al, 2017).
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4.2.4 Gel electrophoresis 
Agarose gel (1.5%) was prepared using 1× TBE buffer (10× TBE buffer: 1M Tris, 1 M Boric 
acid, 50 mM EDTA, [pH 8.3]) and stained with 5 µl ethidium bromide. A Quick load 1kb DNA 
ladder was used as a size standard. Gel electrophoresis was performed at 100 V for 45 min and 
amplicons were visualized under UV light and photographed using a UV transilluminator 




4.3.1 Frequency of putative genotypes in B. melitensis and B. abortus isolates 
From the 120 isolates as shown below in Table 4.2, complete occurrence of betB and bspB 
were found to be 73% and 72% respectively irrespective of the strain. The highest occurrence 
of betB, vceC and bspB (100%) was observed from B. abortus while the lowest occurrence 
was observed in btpA (7%) and prpA (5.6%). There was no virB2 and prpA detected (0%) in 
B. melitensis while betB (34.7%) was the highest virulent-determinant observed for B. 




Figure 4.2: Amplification product from the primer pair of the 9 Putative virulence gene of ND 
19 sample.  Lane M: 1 kb DNA ladder (Inqaba); Lane 1: Negative control, Lane 2: No band, 
Lane 3: PrpA (674bp) gene, Lane 4: No band, Lane 5: BetB (393 bp) gene, Lane 6: (466 bp) 








Table 4.2: Virulence-associated genes prevalence among the 120 Brucella isolates from animal sources 
Target strains No. (%) No. of putative virulence genes in studied strains 
  VirB5 BtpA BtpB VceC BetB BPE275 VirB2 BSPB PrpA 
B. melitensis 49 (41%) 3 (6.1%) 2 (4.1%)   1 (2%) 9 (18.4%) 17 (34.7%) 3 (6.1%) 0 (0%) 9 (18.4%) 0 (0%) 
B. abortus 71 (63%) 10 (14.1%) 24 (33.8%) 5(7%) 71(100%) 71(100%) 70(98.6%) 65(91.5%) 71 (100 %) 4 (5.6%) 
TOTAL 120(100%) 13(11%) 26(22%) 6(5%) 80(67%) 88(73%) 73(61%) 65 (54%) 86 (72%) 4 (3%) 
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4.4 Discussion  
Brucellosis, which is caused by Brucella spp. infection is a disease that can be acquired from 
the aborted fetus or the infected animal body through direct contact with mucosa or abraded 
skin, fluids, and tissue. Brucella gently get into host cells through conjunctivae, respiratory 
tract and abraded skin, spreading through mononuclear phagocytes and finally into 
reticuloendothelial sites, inhibiting bactericidal reactions within macrophages (Saeedzadeh et 
al., 2012; Godfroid et al., 2000; Moreno and Moriyon, 2002; Ugalde et al., 2003; Rajashekara 
et al., 2006; Starr and Wehrly, 2008; Xavier et al., 2010; Brambila-Tapia et al., 2014).  To the 
best of our knowledge, up to now, no article has documented the molecular characterization of 
this specific putative virulence-associated genes isolated from cattle, sheep, and goats in South 
Africa. 
Brucella’s cell envelop protein is very important for its pathogenicity (Brambila-Tapia et al., 
2014). The functioning of the genes is linked to the envelop protein, therefore the envelop 
protein must adapt to environmental stress, intracellular modulatory activity and possess the 
ability to survive. (Sabri et al, 2014). Colonization or elimination of pathogens in host cell is 
usually controlled by the initial interaction between the virulence genes and the envelop 
protein, because they institute signals that lead to the change of gene expression patterns in the 
cell envelope proteins (Awwad et al., 2015), Neta et al., 2010,and Starr & Wehrly, 2008). 
Amongst all the virulence genes in this study, BetB , which encodes betaine dehydrogenase 
(BADH) is one of the most predominant, this gene is responsible for oxidizing betaine aldehyde 
to glysine betaine, which helps maintain stability of osmotic stress in all eukaryotic and 
prokaryotic cells (Lee, 2014), this can explain the ability for the  bacteria to resist any attack 
by the immune systems during infection or transport into the cells, hence increasing its 
pathogenicity (Rossetti, 2017). 
The present study also revealed that a total of 80 Brucella spp. comprising B. abortus (18.4%) 
and B. melitensis (100%) strains contained VceC gene. VceC is an essential precursor of 
Brucella T4SS. It is stated that 20 amino acids at the C-terminal of VceC are needed for their 
displacement into the host cell, even though they're not preserved in all Brucella species 
(Myeni, 2013). The interplay between VceC with ER chaperon, Bip, leads to the positioning of 
VceC to ER that triggers the unfolded protein reaction that induces ER stress, followed by the 





According to Myeni (2013), BspB which forms about 72% of the detected genes in our study, 
together with BspA and BspF was one of the three Bsp genes predicted by bioinformatics and 
later identified by TEM-1 -fusing protein method, which are composed of 191, 187 and 428 
amino acids. These genes appear to be localized at the ER and their function is to inhibit or 
stop the host cells protein secretory pathway when overexpressed in cells that are infected and 
also, they are responsible for preventing cellular secretion during infection of cells (Myeni, 
2013). The overexpression of this genes means that if the other two genes were to be isolated 
also, they would probably be expressed as well, because of the complementary functions of 
these genes. 
Within the T-pilus in A. tumefaciens VirB2 was identified as a major part (Eisenbrandt et 
al.,1999). Conjugative pili of IncP plasmids and the Ti plasmid T pilus are composed of cyclic 
subunits (Lai et al., 1998). As a result, Processed VirB2 is the major subunit of the promiscuous 
pilus of Agrobacterium tumefaciens. Another subunit of the VirB, which is the VirB5 was put 
forward to be a small component at the end of the pilus, which meant it mediates the unique 
adhesion to cells of the recipient as wells as unintended association of VirB5 with the periplasm 
pilus base. Vir Proteins are responsible for stabilizing the VirB5 and Mediate Its Association 
with the T Pilus of A. tumefaciens. The presence of VirB2 and VirB5, even in small amounts, 
their presence alone means the survival of Brucella within the host since they are involved in 
modulation of the host immune response to infection, and adhesion and thus ensuring the 
survival of Brucella (Jong, 2008).  
The low expression of the other genes can be explained by the fact that, because they are found 
in different stages within the infection system, their expression will always differ, and also the 
microenvironment with which the isolation of Brucella was done, hence there will always be 
some genes that will not be highly expressed, while some are highly expressed. However, their 
existence is alarming, as this indicates a lot more to be learned about the Brucella species.  
B. abortus was identified in majority of samples collected from cattle, goat and sheep, and also 
with all the samples analysed for the 9 virulence genes large number of these genes were found 
to be expressed in isolates of  B. abortus with B. melitensis accounting for a small number of 
genes expressed even though, according to Razzaq, et al., (2014) it is the more virulent spp. 
For this study B. abortus was the most isolated Brucella spp than B. melitensis. With all the 
samples analysed, cattle rather sheep or goat samples contained majority of these putative 
virulence genes.  
75 
 
There are genes that are associated with virulence or survival of organisms, characterization of 
these genes will help in development of safe and protective vaccines, like with the development 
of live attenuated vaccines inducing high protection levels (Gheibi, 2018). An example of such 
vaccine development, is the engineering of vaccines based on various deletion in B.abortus 
virulence genes that lead to significant attenuation, including purine biosynthesis pathway 
genes, ferro chelatase hem H mutant, lipid A fatty acid transporting gene, phosphoglycerate 
kinase encoding gene, the LPS biosynthesis pathway genes and the Type IV secretion virB 
genes just to mention a few (Conde-Alvarez, 2013), (Alcantra, 2004), (Trant, 2010) (Hartigh, 
2004) (Ferguson, 2004), and (Almiron, 2001). 
 
4.5 Conclusion and recommendations 
The results of the present study demonstrated that Brucella spp. has a lot of different genes 
responsible for its virulence, and these genes contribute to the infection of Brucella in many 
ways, and expression depends to great degree how infected the host is when the samples were 
collected, and isolated, and environmental factors also plays a role as well. Cattle remain the 
major carrier of Brucella spp, with B. abortus the main isolated spp. Both BetB and BspB 
virulence genes occurred to be dominant amongst Brucella abortus and Brucella melitensis 
isolates, with PrpA virulence gene being the least dominant of the nine genes tested. Therefore, 
more information needs to be circulated especially to the general public about this disease, 
since vaccines are not readily available, especially in the poorer arears, hence Public health 
enlightenment should be focused on the zoonotic aspect of the disease as it relates to 
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*This chapter presents general discussion, conclusion and recommendations for future studies. 
 
5.1. GENERAL DISCUSSION  
Brucella is not readily identified due to its wide variety of hosts, multifaceted epidemiology, 
and the socio-economic implications it has, hence Brucellosis is a “difficult disease”, according 
to Franc et al., (2018). Sanogo et al., (2012) indicated that, livestock farming in Africa has 
many challenges which affect their development, these challenges include parasitic, viral and 
bacterial infectious diseases which are proving hard to manage for the local farmers, resulting 
in huge economic losses through its negative impacts on production, and also a potentially 
debilitating infection of man due to its zoonotic potential.  
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Molecular techniques are very important in the identification of Brucella spp. However, this 
has been used in combination with antibiotics, but the inappropriate use of antibiotics 
ultimately led to emergence of resistant microbial population further emphasizing the 
importance of studying virulence genes and their importance in brucella pathogenesis. 
According to Azam et al., (2018), there is a need for more research into the molecular 
pathobiology and immunological properties of Brucella spp which will then lead into the 
development of better and safer vaccines for both livestock and humans. 
Out of the total antibiotics used in feeds and global antibiotic consumption, tetracyclines and 
beta lactams effectively constitute about 50 percent each respectively (Tiwari et al., 2013). Due 
to the build-up in immunity against antibiotics, most prescribed treatment rarely works as a 
result of resistant bacterium. In the present study, streptomycin was highly resistant followed 
by cephalothin and trimethroprim-sulfamethoxazole respectively. Brucella isolates were also 
susceptible to tetracycline, doxycycline and ciprofloxacin. Misuse of antibiotics is a serious 
problem when dealing with brucellosis in livestock and also in humans. This misuse of 
antibiotics when admistering them, has resulted in several antibiotics not being effective 
anymore and Brucella being resistant. Intermediate resistance was observed on erythromycin 
with Adzitey et al (2012) stating that, organisms that shows intermediate resistance also tend 
to easily become resistant. However, tetracycline, doxycycline and ciprofloxacin can be used 
as antibiotics of choice in our setting.  
The multi antibiotic resistance (MAR) index of our isolates ranges from 0.14-0.57.  At least 
15% of  Brucella isolates were resistant to four antibiotics with MAR index of 0.57, 20 % were 
resistant to three antibiotics with MAR index of 0.43, with  60% of  isolates were resistant to 
two antibiotics with MAR index of 0.29 and finally only 5 % of isolates were resistant to one 
antibiotic with MAR index of 0.14. A MAR index value greater than 0.2 indicate high risk 
source of contamination where antibiotics are often used, and the source has been exposed to 
antibiotics previously (Osundiya et al., 2013). Many feeds used in farms these days contains 
traces amounts of antibiotics, which can also result in acquire resistance. Genetic modification 
or mutation has alo being reported to be major factor in acquiring new resistance against first 
line antibiotics. For example, rifampicin -resistant mutants have been identified in patients who 
previously had brucellosis and recovered, this was reported after they relapsed (Maurin, 2015). 
As a result, this can also further provide proof that the Brucella species can have acquired 
resistance to rifampin antibiotic. 
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Resistance to trimethroprim-sulfamethoxazole was observed in majority of Brucella isolates, 
this antibiotic is highly recommended for brucellosis treatment, mainly in children of younger 
than 8 years of age (Osundiya et al., 2013). Streptomycin is also used to treat brucellosis, it 
indicated 100% resistance, which means that it cannot be used to effectively treat Brucella 
pathogen. Multidrug resistance was observed in most if not all of the isolates, this in return is 
a serious issue as raw milk, mainly from cattle available to workers and the community in these 
rural areas may act as a major vector for transmission of antibiotic resistant Brucella strains 
that can cause serious health risks to humans consuming the unpasteurized milk. The antibiotic 
resistant strains are exacerbated by the presence of virulence factors.   
The absence of classical virulence factors such as exotoxin, endotoxin lipopolysaccharide 
(LPS), capsule, pilus and cytolysin does not prevent Brucella from surviving and replicating 
within the host, this is because they use smart mechanisms for invasion (Pizzaro-Cerda et al., 
2000), such as BvrR and BvrS. These two components of regulatory systems function by 
changing the host’s cell cytoskeleton upon Brucella invasion (Lopez-Goni et al., 2002).  
Brucella spp. contains a wide variety of virulent factors as seen from this study, with different 
functions, one of these virulent factors is Cyclic b-1,2-glucan synthase (Cgs) which is 
responsible for complex formation of host-cell interaction (Guidolin et al., 2018 and Guidolin 
et al., 2015).   
Other systems that assist with invasion are the Type IV secretion systems (T4SSs), which assist 
by avoiding fusion of the phagosome with lysosome (Marchesini et al., 2016 and Hartigh et 
al., 2008) ensuring survival intra-cellularly. Evasion of host immunity is very crucial for 
Brucella survival, hence the integrity of LPS on the Brucella surface appears to be crucial as it 
does not exhibit strong endotoxic activity (Lapaque et al., 2005).  
Virulence factors which were present in this study are VirB2, VirB5, VceC, BtpA, BtpB, BetB, 
Bpe275 and BspB which were present in all Brucella isolates accept PrpA virulence gene, 
which was the only absent gene amongst the studied genes. Majority of these virulence genes 
analysed were from isolates identified as B. abortus, and with B. melitensis accounting for a 
small number of genes expressed even though, according to Razzaq et al., (2014) it is the more 
virulent spp.  
The findings of the present study showed that most Brucella isolates from this region (Eastern 
Cape in South Africa) have virulence factor in their genome and B arbotus remains the most 
isolated Brucella spp. from wide range of livestock (sheep, cattle and goats). B. abortus further 
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demonstrated that it also contains more virulence factors than B. melitensis even though it is 
more prevalent from cattles. Therefore, Brucella spp. needs to be given immediate 
consideration, distribution of information, because a lot of farmers don’t know, and sometimes 
this is a serious issue as all the preventative measures that are being used might be based on 
old information. A thorough understanding of virulence factors and the molecular properties 
of the different isolates of Brucella in this region can help to control brucellosis. 
 
5.2. CONCLUSION 
It’s clear that Brucellosis prevention and treatment is a multifaced approach, not only are 
antibiotics important in treatment, but also knowledge of factors causing virulence has become 
very important over the years due to rapid rise in antibiotic resistance. This study provides 
evidence that commonly prescribed antibiotics may no longer be effective against Brucella 
species. Brucella species showed high resistance to antibiotics such as streptomycin (s), 
trimethroprim-sulfamethoxazole (ts) and cephalotin (cip). A significant number of Brucella 
isolate had a MAR index > 0.2 indicating their source to be from high-risk sources, being 
previously exposed to antibiotics. High rate and increasing trend of resistance causes the use 
of antibiotics to decrease in clinical practice. However, tetracycline, ciprofloxacin and 
doxycline antibiotics may still be of benefit in treating brucellosis because Brucella species are 
more sensitive to them.  
From this study, multiple virulence genes involved in pathogenesis of Brucella were identified, 
from the same isolates. All these isolates are from one area, meaning that, there is a need to 
conduct more research involving virulence factors because there might be more genes that are 
not yet discovered.  Because Brucella is mainly found in sheep, goats, and cattle, they pose a 
serious health risk to humans’ exposure, as these are animals that humans come into contact 
the most, so there is therefore the need for adequate risk prevention strategies to protect the 
animals and preserve public health. 
 
5.3. RECOMMENDATION  
Existing contact sessions between government veterinary services and cattle farmers could be 
utilised optimally to create awareness of brucellosis and to provide relevant information on 
animal and human health and disease prevention. Information transfer would probably be more 
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efficient if provided through methods that are acceptable to the community. Non-compliance 
for farmers is a problem, especially for rural farmers. Because information is known on which 
Brucella species are more dominant, vaccines can be developed that can be more specific to 
those species, and those vaccines can be made readily available, even for rural and poor 
farmers. Because many farmers allow their livestock to graze normally in the field, they can be 
trained on how to deliver the vaccines easily and also how to minimize human transmissions 
as well.  
Proper education, training and communication remain the main focus when combating 
Brucellosis, so awareness campaigns have to be increased to accommodate every farmer, big 
or small and not wait for the farmers to approach the authorities but the authorities to approach 
the farmers to force compliance. This in turn will help decrease misuse of antibiotics, and also 
resolving the multidrug resistance issue currently experienced in the livestock farming in rural 
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Figure 3.3: PCR products for the detection of B. melitensis in raw milk, blood and lymph node 
tissue samples.  Lane M: 100 bp DNA Ladder (Fermentas); Lane 1: 13047K, Lane 2: Negative 
control, Lane 3: 24, Lane 4: 212, Lane 5: 129, lane 6: 10026K    Lane 7: ST13, Lane 8: EH35, 
Lane 9: EH 34, and Lane 10: ND12. The expected molecular size of the IS711+BM fragments 
is 731 bp. 
    
 





Figure 3.4: PCR products for the detection of B. abortus vaccine strain S19 in raw milk, blood 
and lymph node tissue samples.  Lane M: Universal DNA ladder (Kapa); Lane 1: 13047K, 
Lane 2: Negative control, Lane 3: 24, Lane 4: 212, Lane 5: 129, lane 6: 10026K    Lane 7: 
ST13, Lane 8: EH35, Lane 9: EH 34 and Lane 10: ND12. The expected molecular size of the 





Appendix II for Chapter 4 
 
 





Figure 4.3: Amplification product from the primer pair of the 9 Putative virulence gene of 147 
sample.  Lane M: 1 kb DNA ladder (Inqaba); Lane 1: Negative control, Lane 2: VirB5 (274bp), 
Lane 5: BtpA (458 bp) gene, lane 6: Bet B (393 bp) gene, Lane 7: Btp B (579) gene, Lane 8: 
VceC (482 bp) gene, Lane 9: BSPB (336 bp) gene. 
 
 
Figure 4.4: Amplification product from the primer pair of the 9 Putative virulence gene of 12T 
sample.  Lane M: 1 kb DNA ladder (Inqaba); Lane 1: Negative control, Lane 2: VirB5 (274bp) 
gene, Lane 3: BPE275 (466 bp) gene, Lane 5: BtpA (458 bp) gene, lane 6: Bet B (393 bp) gene, 
Lane 7: Btp B (579) gene, Lane 9: BSPB (336 bp) gene.  
 
